NCT03156374

Brief Summary

This proof of concept study is designed to determine the practicality of using home ovulation tests to enable optimum timing for transfer of frozen embryos in a natural menstrual cycle in comparison to the standard ultrasound and serum monitoring currently conducted by many IVF clinics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2017

Completed
2 days until next milestone

Study Start

First participant enrolled

April 30, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 17, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

February 8, 2021

Status Verified

February 1, 2021

Enrollment Period

2.3 years

First QC Date

April 28, 2017

Last Update Submit

February 4, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of volunteers where ADOT use enables equivalent timing of FET compared to clinic visit

    Examination as to whether using ADOT would have enabled correct timing of FET when compared to clinic visit

    9 months

Secondary Outcomes (3)

  • Measurement of women's psychological distress

    9 months

  • Positive and negative experience in using ovulation tests in FET

    9 months

  • FET success

    9 months

Study Arms (1)

Ovulation test use

EXPERIMENTAL

Use of both ovulation tests and standardised care

Device: Test use

Interventions

Test useDEVICE

Use of home ovulation test to predict ovulation

Ovulation test use

Eligibility Criteria

Age24 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBiological women only
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 24 to 45 years of age
  • Undergoing no more than 5frozen embryo transfer
  • Average cycle length between 26 and 35 days
  • Willing to provide written informed consent to participate in the study and comply with all study procedures

You may not qualify if:

  • More than five IVF frozen embryo cycle
  • Undergoing FET following cancer treatment
  • Self-reported drug or alcohol dependency
  • Self-reported history of depression, anxiety and panic attacks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IVFAustralia - Bondi Junction

Bondi Junction, New South Wales, NSW 2022, Australia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Parallel use of ovulation test and standard hospital monitoring, for agreement of methods
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2017

First Posted

May 17, 2017

Study Start

April 30, 2017

Primary Completion

August 28, 2019

Study Completion

September 30, 2019

Last Updated

February 8, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations